SIGY Chart by TradingView
Business Description
SIGY is a medical technology company focused on the treatment of life-threatening inflammatory conditions caused by cytokine storm syndrome. The company has developed a blood purification medical device, and is progressing towards receiving FDA approval to begin human clinical trials. Sigyn is headquartered in San Diego, California, and went public in October 2020.
Website https://www.sigyntherapeutics.com/
FRC Analyst's Reports
| Sigyn Therapeutics Inc. (OTC PINK: SIGY) – A Potential Solution for The Primary Cause of Death During the COVID-19 Pandemic – Initiating Coverage |
Feb. 25, 2022 |
This company was mentioned in the following "Analysts’ Ideas Of The Week":
| This Metal Should Benefit from a Ban on Russian Metals |
Oct 11, 2022 |
| Lowering Our Price Forecasts for These Two Metals | Sep 20, 2022 |
| Expecting the Fed to Take This Stance in Next Meeting | Aug 9, 2022 |
